Skip to main content
Clinical Trials/DRKS00008764
DRKS00008764
Recruiting
N/A

Characterization of the role of blood circulation and neovascularization in acute and chronic pruritus - iETOP

Charité - Universitätsmedizin Berlin0 sites40 target enrollmentJuly 10, 2015

Overview

Phase
N/A
Intervention
Not specified
Conditions
chronic pruritus in patients suffering from prurigoAcute pruritus in itching modelsHealthy volunteers
Sponsor
Charité - Universitätsmedizin Berlin
Enrollment
40
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 10, 2015
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria healthy subjects:
  • The volunteers must be over eighteen, and be able to communicate with the investigator. They must be able to understand the contents of the study and they need to consent to participate in the study. Only male subjects.
  • Inclusion criteria patients:
  • 1\. Signed informed consent
  • 2\. Prurigo patients with chronic pruritus (\> 6 months) and a severity of prurigo using VAS \= 6/10
  • 3\. The patient willing to only use the mentioned products and no other own externa. As rescue medication in severe itching, patients receive a care cream DAC base cream that can be applied as often as desired.
  • 4\. Of full age
  • 5\. Both male and female patients

Exclusion Criteria

  • Exclusion criteria subjects:
  • Known history of hypersensitivity to any of the substances to be applied.
  • Regular or current intake of medications against itch such as antihistamines, topical or systemic steroids, immunosuppressants or gabapentin.
  • Participation in a clinical trial in the last 30 days.
  • Exclusion criteria patients:
  • 1\. Therapeutic UV radiation during the last 6 weeks before the start of the investigation or during the investigation
  • 2\. Topical antihistamines, steroids or mast cell stabilizers in the last 3 weeks prior to the study or during the study
  • 3\. Systemic medications such antihistamnika, antidepressants, antipsychotics, corticosteroids are permitted if:
  • a) the medication were taken since at least the last 4 weeks prior to the study and
  • b) there has been no changes regarding the use or dosage during the study

Outcomes

Primary Outcomes

Not specified

Similar Trials